RetinaCME
LECTURECME

Long-term Management of Neovascular Age-related Macular Degeneration: Trends in Treatment

Author(s)/Faculty: Peter K. Kaiser, MD; Sophie J. Bakri, MD; Rishi P. Singh, MD
Release Date: 4/23/2018Expiration Date: 4/22/2019
Credit Type: CMENumber of Credits: 0.5
Content Type: LectureProvider: Vindico Medical Education
Age-related macular degeneration (AMD) is a leading cause of severe vision loss among people aged 50 years and older. It is estimated that nearly 3 million individuals in the United States will develop AMD by 2020 and that the prevalence will continue to increase due to the aging population. Intravitreal anti-vascular endothelial growth factor (VEGF) therapy has revolutionized the treatment of neovascular AMD. However, questions regarding treatment strategies to achieve optimum long-term outcomes are still being elucidated. In this CME activity, experts in the field assess variabilities in the management of neovascular AMD, evaluate protocols for the effective long-term treatment of neovascular AMD, and provide review and guidance for effective disease management, through the presentation and discussion of clinical cases.